She-gan W. Gao
Luoyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Correction: Development and validation of a multimodal deep learning model for early esophageal squamous neoplasia detection and invasion depth prediction.
Journal: Endoscopy
Published: March 13, 2026
Development and validation of a multimodal deep learning model for early esophageal squamous neoplasia detection and invasion depth prediction.
Journal: Endoscopy
Published: December 30, 2025
Development and validation of a multimodal deep learning model for early esophageal squamous neoplasia detection and invasion depth prediction.
Journal: Endoscopy
Published: December 30, 2025
Ethnic genomic differences in esophageal squamous cell carcinoma: Whole-exome sequencing of Han and Kazakh populations in China.
Journal: World journal of gastroenterology
Published: August 04, 2025
Roles and inhibitors of FAK in cancer: current advances and future directions.
Journal: Frontiers in pharmacology
Published: August 08, 2023
A new prognostic model of esophageal squamous cell carcinoma based on Cloud-least squares support vector machine.
Journal: Journal of thoracic disease
Published: July 06, 2023
High glucose-increased miR-200c contributes to cellular senescence and DNA damage in neural stem cells.
Journal: Birth defects research
Published: July 04, 2022
N-linked glycoproteomic profiling in esophageal squamous cell carcinoma.
Journal: World journal of gastroenterology
Published: January 14, 2022
A Prognostic Model Based on mRNA Expression Analysis of Esophageal Squamous Cell Carcinoma.
Journal: Frontiers in bioengineering and biotechnology
Published: November 27, 2021
CRISPR/Cas9-mediated gene editing on Sox2ot promoter leads to its truncated expression and does not influence neural tube closure and embryonic development in mice.
Journal: Biochemical and biophysical research communications
Published: July 22, 2021
A one-step platform for screening high-efficient and minimal off-target CRISPR/Cas13 crRNAs to eradicate SARS-CoV-2 virus for treatment of COVID-19 patients.
Journal: Medical hypotheses
Published: June 19, 2021
Last Updated: 09/26/2026